[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET.

UNLABELLED Our objective was to investigate the properties of [1-(11)C]acetate as a quantitative perfusion tracer for myocardial PET studies. METHODS We determined the flow dependence of the effective acetate extraction by a comparison with [(13)N]ammonia in 24 patients at rest (n = 8) and under pharmacologic vasodilation (n = 16). Furthermore, we compared the statistical quality of the perfusion values derived with both tracers. Quantification was based on an irreversible 2-compartment model for [(13)N]ammonia and a reversible 1-compartment model for [1-(11)C]acetate. Area-conserving polar maps were used to determine the correlation between the unidirectional uptake parameters of both tracers on a pixel-by-pixel basis for the whole left ventricular myocardium. RESULTS A fit of a generalized Renkin-Crone formula to the data yielded the unidirectional acetate extraction fraction E(f) = 1 - 0.64e(-1.20/f). An extraction correction based on this formula led to good quantitative agreement of perfusion values derived with [(13)N]ammonia and [1-(11)C]acetate over the whole observed flow range (average difference of flow values, 3%; correlation coefficient, 0.96). This agreement proved the applicability of acetate as a quantitative perfusion tracer even under stress conditions. An analysis of the statistical properties of the parameter estimates showed, moreover, that statistical errors were reduced by a factor of nearly 2 in comparison with ammonia. CONCLUSION [1-(11)C]acetate allows accurate quantification of myocardial perfusion with PET at rest as well as under stress conditions. The use of acetate leads to distinctly improved statistical accuracy for the perfusion estimates in comparison with ammonia. This accuracy facilitates the generation of reliable parametric polar maps, which are especially useful for clinical application of myocardial perfusion quantification.

[1]  M E Phelps,et al.  13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.

[2]  N. Sadato,et al.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states , 1992, Annals of nuclear medicine.

[3]  H. Schelbert,et al.  Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. , 1993, The American journal of cardiology.

[4]  B E Sobel,et al.  Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. , 1987, Circulation.

[5]  D. Kuhl,et al.  Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  M E Phelps,et al.  Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  S S Gambhir,et al.  Quantification of Regional Myocardial Blood Flow Using 13N‐Ammonia and Reoriented Dynamic Positron Emission Tomographic Imaging , 1992, Circulation.

[8]  William H. Press,et al.  Numerical recipes in C , 2002 .

[9]  D. Kuhl,et al.  N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.

[10]  M. Walsh,et al.  Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  M. Phelps,et al.  Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. van den Hoff,et al.  A kinetic model for cardiac PET with [1-carbon-11]-acetate. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  G. Hutchins,et al.  Metabolic fate of [13N]ammonia in human and canine blood. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Phelps,et al.  Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. , 1993, Circulation.

[15]  S. Bergmann,et al.  Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  M. Phelps,et al.  A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. van den Hoff,et al.  Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction. , 1997, Circulation.

[18]  R. Gropler,et al.  Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  M. Phelps,et al.  Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  A. Luxen,et al.  Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. , 1989, Circulation.

[21]  M. Schwaiger,et al.  Assessment of myocardial oxidative metabolism in aortic valve disease using positron emission tomography with C-11 acetate. , 1992, American heart journal.

[22]  H R Schelbert,et al.  Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. , 1990, Circulation.

[23]  E. Topol,et al.  Use of carbon-11 acetate and dynamic positron emission tomography to assess regional myocardial oxygen consumption in patients with acute myocardial infarction receiving thrombolysis or coronary angioplasty. , 1993, The American journal of cardiology.

[24]  E. M. Renkin Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. , 1959, The American journal of physiology.

[25]  G. Hutchins,et al.  A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  C. Crone,et al.  THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD. , 1963, Acta physiologica Scandinavica.

[27]  S. Bergmann,et al.  Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. , 1988, Journal of the American College of Cardiology.

[28]  M. Schwaiger,et al.  Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[29]  S. Cherry,et al.  Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging , 1999, European Journal of Nuclear Medicine.

[30]  M Schwaiger,et al.  Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  C. Ng,et al.  Validation of a model for [1-11C]acetate as a tracer of cardiac oxidative metabolism. , 1994, The American journal of physiology.

[32]  G Blomqvist,et al.  On the Construction of Functional Maps in Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  Simple and Patlak models for myocardial blood flow measurements with nitrogen-13-ammonia and PET in humans. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  R. Gropler,et al.  Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. , 1993, Journal of the American College of Cardiology.

[35]  D E Kuhl,et al.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.

[36]  M E Phelps,et al.  Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. , 1989, Circulation.

[37]  M. Phelps,et al.  A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. , 1991, Journal of the American College of Cardiology.

[38]  William H. Press,et al.  Numerical Recipes in C, 2nd Edition , 1992 .

[39]  S. Bergmann,et al.  Functional recovery after reperfusion is predicated on recovery of myocardial oxidative metabolism. , 1993, American heart journal.